The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1255 articles
Desperate individuals seeking weight-loss injections are endangering their health by purchasing counterfeit products from unregulated sellers, pharmacists caution. These fake jabs may contain insulin, causing severe hypoglycemia. Polling indicates growing interest in such treatments, highlighting the need for caution.
Pharmaceutical giants like Novo Nordisk and Eli Lilly are transforming GLP-1 drugs into everyday consumer products, introducing oral versions and emphasizing cash-pay models. This shift, driven by telehealth and apps, aims to make weight loss as accessible as online shopping, while experts raise concerns about medical oversight.
The United States Food and Drug Administration has greenlit the initial tablet form of a GLP-1 drug designed for shedding pounds, which might considerably broaden availability of obesity therapies. Produced by the Danish firm Novo Nordisk, this daily Wegovy pill is set to debut in early January, with clinical trial participants averaging a 16.6% drop in body weight.
Pop sensation Demi Lovato has released previously unseen swimsuit photos to mark the year and welcome the new one, proudly showing off her transformed physique after losing 50lbs. Speculation surrounds her potential use of GLP-1 agonist medications, with a list of celebrities who've admitted to similar treatments. Additionally, Lovato reflects on her personal achievements, including marriage and upcoming tours.
Tirzepatide, known as Mounjaro or Zepbound, serves as a medication for diabetes and weight management but comes with a steep price. Without insurance, monthly expenses can range from $500 to $1,900, varying by type and purchase location. This piece explores pricing details, insurance coverage, cost-saving strategies, and budget-friendly substitutes.
Using GLP-1 drugs for weight loss can suppress appetite, making it challenging to fuel properly during runs. This article explores the risks of underfueling and provides expert tips to maintain energy and health. Learn how to adjust your training and nutrition to avoid issues like muscle loss and fatigue while on these medications.
Weight loss medications such as Wegovy and Zepbound are set to become more accessible and affordable, moving beyond high costs and weekly shots. New pill forms offer alternatives for those avoiding injections, with significant developments in GLP-1 treatments expected. Advances in pricing and access programs aim to broaden availability for patients.
The year 2025 has seen a relentless barrage of ads promoting GLP-1 medications for weight loss, often bypassing FDA approvals and focusing on cosmetic benefits. Despite regulations limiting their use to specific medical conditions, telehealth companies push compounded versions aggressively. This trend threatens to undermine the body positivity movement by exploiting insecurities for profit.
The landscape of GLP-1 medications for weight loss is shifting towards consumer-driven models, with pill versions offering flexibility and telehealth platforms making access easier. Industry experts envision daily routines incorporating these drugs alongside apps, while concerns arise about medical oversight and long-term effects. This evolution could expand the market significantly, driven by affordability and marketing.
